University of Massachusetts and colleagues at Brigham and Women’s Hospital report that in preclinical models they can amplify macrophage immune responses against cancer using a self-assembling supramolecule.

https://m.medicalxpress.com/news/2018-07-cancer-immunotherapy-early.html